Cited by 193Cardiac electrophysiology and arrhythmiasCardiac Arrhythmias and TreatmentsPharmacovigilance and Adverse Drug Reactions

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide

Open access

Fish, Frank A, Gillette, Paul C, Benson, D.Woodrow·1991·Journal of the American College of Cardiology

DOI 10.1016/0735-1097(91)90586-x

Open this paper in CoChat — free account Open PDF

Abstract

The potential for proarrhythmic responses to the class IC sodium channel-blocking drugs encainide and flecainide has not been well described in young patients. Therefore, data were retrospectively collected from 36 institutions regarding 579 young patients who were administered encainide or flecainide for treatment of supraventricular tachycardias (encainide 86 patients, flecainide 369 patients) or ventricular arrhythmias (encainide 21 patients, flecainide 103 patients) to assess the frequency of proarrhythmia, cardiac arrest and death during therapy (adverse events). The two drugs were similar in regard to efficacy (flecainide 71.4%, encainide 59.8%) and rate of proarrhythmic responses (flecainide 7.4%; encainide 7.5%). However, patients receiving encainide more frequently experienced cardiac arrest (encainide 7.5% vs. flecainide 2.3%, p less than 0.05) or died during treatment (encainide 7.5% vs. flecainide 2.1%, p less than 0.05). Detailed data were provided for 44 patients experiencing one or more adverse events. Patient age, previous drug trials, concomitant therapy and days of inpatient monitoring were similar for patients receiving encainide or flecainide. However, echocardiographic left ventricular shortening before treatment was lower among patients receiving encainide (0.23 +/- 0.09) than among those receiving flecainide (0.34 +/- 0.06, p less than 0.05). Plasma drug concentrations were rarely elevated. Cardiac arrest (12 patients) and deaths (13 patients) occurred predominantly among patients with underlying heart disease, particularly among patients receiving flecainide for supraventricular tachycardia (8.3% vs. 0.3%, p less than 0.001). Fifteen patients with an ostensibly normal heart and normal ventricular function experienced proarrhythmia during treatment for supraventricular tachycardia, but only 3 of the 15 had a cardiac arrest or died. The relatively high incidence of adverse events should be considered when contemplating treatment with encainide or flecainide, particularly among patients with underlying heart disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/0735-1097(91)90586-x

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210629 · Cited by 3,289
The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction.
Weir, M. (1990) · Cardiopulmonary Physical Therapy Journal · doi:10.1097/01823246-199001020-00009 · Cited by 1,061
Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.
Coplen, S. E., Antman, E. M., Berlin, J. A., Hewitt, P., & Chalmers, T. C. (1990) · Circulation · doi:10.1161/01.cir.82.4.1106 · Cited by 946
Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.
Velebit, V., Podrid, P. J., Lown, B., Cohen, B. H., & Graboys, T. B. (1982) · Circulation · doi:10.1161/01.cir.65.5.886 · Cited by 629
Atrial flutter in the young: A collaborative study of 380 cases
Garson, A., Bink‐Boelkens, M. T. E., Hesslein, P. S., Hordof, A. J., Keane, J. F., Neches, W. H., & Porter, C.-B. J. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80497-6 · Cited by 347
Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.
Anderson, J. L., Gilbert, E. M., Alpert, B. L., Henthorn, R. W., Waldo, A. L., Bhandari, A. K., Hawkinson, R. W., & Pritchett, E. L. C. (1989) · Circulation · doi:10.1161/01.cir.80.6.1557 · Cited by 287
Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogram
Morganroth, J., & Horowitz, L. N. (1984) · The American Journal of Cardiology · doi:10.1016/0002-9149(84)90509-5 · Cited by 280
Oral Flecainide Acetate for the Treatment of Ventricular Arrhythmias
Anderson, J. L., Stewart, J. R., Perry, B. A., Hamersveld, D. D. V., Johnson, T. A., Conard, G. J., Chang, S. F., Kvam, D. C., & Pitt, B. (1981) · New England Journal of Medicine · doi:10.1056/nejm198108273050901 · Cited by 222
Malignant ventricular tachyarrhythmias associated with the use of encainide
Winkle, R. A., Mason, J. W., Griffin, J. C., & Ross, D. L. (1981) · American Heart Journal · doi:10.1016/0002-8703(81)90036-3 · Cited by 212
Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter
Gelder, I. C. V., Crijns, H. J. G. M., van Gilst, W. H., van Wijk, L. M., Hamer, H. P. M., & Lie, K. I. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90574-2 · Cited by 187

Show all 37 references

Sorted by citations

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A. M., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 3,145
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,975
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.054 · Cited by 1,902
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.178233 · Cited by 1,080
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.017 · Cited by 933
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Moss, A. J., Myerburg, R. J., et al. (2006) · EP Europace · doi:10.1093/europace/eul108 · Cited by 741
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000549 · Cited by 777
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.035 · Cited by 743
PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease
Khairy, P., Van Hare, G. F., Balaji, S., Berul, C. I., Cecchin, F., Cohen, M. I., Daniels, C. J., Deal, B. J., Dearani, J. A., Groot, N. D., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.05.009 · Cited by 709
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.053 · Cited by 689
2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
Al‐Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T. M., Field, M. E., Fonarow, G. C., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.10.036 · Cited by 644
The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation
Andrade, J. G., Aguilar, M., Atzema, C. L., Bell, A., Cairns, J. A., Cheung, C. C., Cox, J. L., Dorian, P., Gladstone, D. J., Healey, J. S., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.09.001 · Cited by 593
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death—executive summary
Zipes, D. P., Camm, A. J., Borggrefe, M. M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Moss, A. J., Myerburg, R. J., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl199 · Cited by 519
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.856 · Cited by 439
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000548 · Cited by 412
Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement
Brugada, J., Blom, N. A., Sarquella‐Brugada, G., Blomström‐Lundqvist, C., Deanfield, J. E., Janoušek, J., Abrams, D. J., Bauersfeld, U., Brugada, R., Drago, F., et al. (2013) · EP Europace · doi:10.1093/europace/eut082 · Cited by 397
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias
Pedersen, C. T., Kay, G. N., Kalman, J. M., Borggrefe, M., Bella, P. E. D., Dickfeld, T. M., Dorian, P., Huikuri, H. V., Kim, Y., Knight, B. P., et al. (2014) · EP Europace · doi:10.1093/europace/euu194 · Cited by 331
Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE
Hernández‐Madrid, A., Paul, T., Abrams, D. J., Aziz, P. F., Blom, N. A., Chen, J., Chessa, M., Combes, N., Dagres, N., Diller, G., et al. (2018) · EP Europace · doi:10.1093/europace/eux380 · Cited by 327
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias
Pedersen, C. T., Kay, G. N., Kalman, J., Borggrefe, M., Della-Bella, P., Dickfeld, T., Dorian, P., Huikuri, H., Kim, Y.-H., Knight, B., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.07.024 · Cited by 288
PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease
Khairy, P., Hare, G. F. V., Balaji, S., Berul, C. I., Cecchin, F., Cohen, M. I., Daniels, C. J., Deal, B. J., Dearani, J. A., de Groot, N. M. S., et al. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.09.002 · Cited by 252
Management outcome and follow-up of fetal tachycardia
van Engelen, A. D., Weijtens, O., Brenner, J. I., Kleinman, C. S., Copel, J. A., Stoutenbeek, P., & Meijboom, E. J. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90122-8 · Cited by 219
2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H. G., CONTI, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.09.019 · Cited by 213
European Heart Rhythm Association (EHRA) consensus document on the management of supraventricular arrhythmias, endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE)
Katritsis, D. G., Boriani, G., Cosio, F. G., Hindricks, G., Jaïs, P., Josephson, M. E., Keegan, R., Kim, Y.-H., Knight, B. P., Kuck, K.-H., et al. (2017) · Europace · doi:10.1093/europace/euw301 · Cited by 188
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death—Executive Summary
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.008 · Cited by 184
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H. G., CONTI, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000310 · Cited by 186
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000311 · Cited by 595
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
Ono, K., Iwasaki, Y., Akao, M., Ikeda, T., Ishii, K., Inden, Y., Kusano, K., Kobayashi, Y., Koretsune, Y., Sasano, T., et al. (2022) · Circulation Journal · doi:10.1253/circj.cj-20-1212 · Cited by 132
Fetal cardiac arrhythmia detection and in utero therapy
Strasburger, J. F., & Wakai, R. T. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.32 · Cited by 128
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death—Executive Summary
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Moss, A. J., Myerburg, R. J., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.178104 · Cited by 119
The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia
Frohn-Mulder, I. M. E., Stewart, P. A., Witsenburg, M., den Hollander, N. S., Wladimiroff, J. W., & Hess, J. (1995) · Prenatal Diagnosis · doi:10.1002/pd.1970151309 · Cited by 111
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H. G., CONTI, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.09.019 · Cited by 100
Efficacy and proarrhythmia of oral sotalol in pediatric patients
Pfammatter, J. P., Paul, T., Lehmann, C., & Kallfelz, H. C. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00268-3 · Cited by 99
Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology
Merino, J. L., Tamargo, J. L., Blomström‐Lundqvist, C., Boriani, G., Crijns, H. J. G. M., Dobrev, D., Goette, A., Hohnloser, S. H., Naccarelli, G. V., Reiffel, J. A., et al. (2025) · EP Europace · doi:10.1093/europace/euaf076 · Cited by 112
The Study of Antiarrhythmic Medications in Infancy (SAMIS)
Sanatani, S., Potts, J. E., Reed, J. H. C., Saul, J. P., Stephenson, E. A., Gibbs, K., Anderson, C. C., Mackie, A. S., Ro, P. S., Tisma‐Dupanovic, S., et al. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.972620 · Cited by 95
Flecainide acetate for treatment of tachyarrhythmias in children: Review of world literature on efficacy, safety, and dosing
Perry, J. C., & Garson, A. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90081-6 · Cited by 92
Management Strategy for Fetal Tachycardia
Cuneo, B. F., & Strasburger, J. F. (2000) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)00996-0 · Cited by 87
Initial experience with the maze procedure for atrial fibrillation
McCarthy, P. M., CASTLE, L. W., Maloney, J. D., Trohman, R. G., Simmons, T. W., White, R. D., Klein, A. L., & Cosgrove, D. M. (1993) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)33782-1 · Cited by 82
Drug Treatment of Fetal Tachycardias
Oudijk, M. A., Ruskamp, J. M., Ambachtsheer, B. E., Ververs, T. F., Stoutenbeek, P., Visser, G. H. A., & Meijboom, E. J. (2002) · Pediatric Drugs · doi:10.2165/00128072-200204010-00006 · Cited by 80
Clinical spectrum, therapeutic management, and follow-up of ventricular tachycardia in infants and young children
Davis, A. M., Gow, R. M., McCrindle, B. W., & Hamilton, R. M. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90068-x · Cited by 79
Pharmacologic Management of Supraventricular Tachycardias in Children. Part 2: Atrial Flutter, Atrial Fibrillation, and Junctional and Atrial Ectopic Tachycardia
Luedtke, S. A., Kuhn, R. J., & McCaffrey, F. M. (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703101113 · Cited by 74
Supraventricular Tachycardia in Infants, Children and Adolescents
Paul, T., Bertram, H., B�kenkamp, R., & Hausdorf, G. (2000) · Pediatric Drugs · doi:10.2165/00128072-200002030-00002 · Cited by 71
Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age
Price, J. F., Kertesz, N. J., Snyder, C. S., Friedman, R. A., & Fenrich, A. L. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01773-9 · Cited by 70
Safety of Oral Propafenone in the Treatment of Arrhythmias in Infants and Children (European Retrospective Multicenter Study)
Janoušek, J., & Paul, T. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00142-8 · Cited by 67
Pharmacologic Management of Supraventricular Tachycardias in Children
Luedtke, S. A., Kuhn, R. J., & McCaffrey, F. M. (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703101016 · Cited by 67
Ventricular Arrhythmias: When to Worry
Alexander, M. E., & Berul, C. I. (2000) · Pediatric Cardiology · doi:10.1007/s002460010131 · Cited by 65
Dofetilide for Atrial Arrhythmias in Congenital Heart Disease: A Multicenter Study
Wells, R., Khairy, P., Harris, L., Anderson, C. C., & Balaji, S. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02479.x · Cited by 62
Efficacy and safety of propafenone in congenital junctional ectopic tachycardia
Paul, T., Reimer, A., Janoušek, J., & Kallfelz, H.-C. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90192-p · Cited by 58
Treatment of atrial ectopic tachycardia in infants <6 months old
Bauersfeld, U., Gow, R. M., Hamilton, R. M., & Izukawa, T. (1995) · American Heart Journal · doi:10.1016/0002-8703(95)90396-8 · Cited by 53
Atrial fibrillation in adults with congenital heart disease
Waldmann, V., Laredo, M., Abadir, S., Mondesert, B. A., & Khairy, P. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.01.079 · Cited by 53
New antiarrhythmic drugs in pediatric use: Propafenone
Paul, T., & Janoušek, J. (1994) · Pediatric Cardiology · doi:10.1007/bf00800674 · Cited by 50
Role of abnormal repolarization in the mechanism of cardiac arrhythmia
Osadchii, O. E. (2017) · Acta Physiologica · doi:10.1111/apha.12902 · Cited by 49
Indications for Radiofrequency Ablation in the Pediatric Population
Hare, G. F. V. (1997) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1997.tb00857.x · Cited by 48
Digoxin or flecainide for prophylaxis of supraventricular tachycardia in infants?
O’Sullivan, J., Gardiner, H. M., & Wren, C. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00291-9 · Cited by 47
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias
Pedersen, C. T., Kay, G. N., Kalman, J. M., Borggrefe, M., Bella, P. E. D., Dickfeld, T. M., Dorian, P., Huikuri, H. V., Kim, Y. D., Knight, B. P., et al. (2014) · Journal of Arrhythmia · doi:10.1016/j.joa.2014.08.001 · Cited by 44
PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: Executive Summary
Khairy, P., Hare, G. F. V., Balaji, S., Berul, C. I., Cecchin, F., Cohen, M. I., Daniels, C. J., Deal, B. J., Dearani, J. A., de Groot, N. M. S., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.05.008 · Cited by 45
JCS / JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
Ono, K., Iwasaki, Y., Akao, M., Ikeda, T., Ishii, K., Inden, Y., Kusano, K., Kobayashi, Y., Koretsune, Y., Sasano, T., et al. (2022) · Journal of Arrhythmia · doi:10.1002/joa3.12714 · Cited by 41
Atrial tachycardias in young adults and adolescents with congenital heart disease: Conversion using single dose oral sotalol
Rao, S. O., Boramanand, N. K., Burton, D. A., & Perry, J. C. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.04.060 · Cited by 43
Extracorporeal membrane oxygenation support for intractable primary arrhythmias and complete congenital heart block in newborns and infants
Dyamenahalli, U., Tuzcu, V., Fontenot, E., Papagiannis, J. K., Jaquiss, R. D. B., Bhutta, A. T., Morrow, W. R., Erickson, C. C., Imamura, M., & Prodhan, P. (2011) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0b013e3182196cb1 · Cited by 43
New Antiarrhythmic Drug in Pediatric Use: Sotalol
Pfammatter, J., & Paul, T. (1997) · Pediatric Cardiology · doi:10.1007/s002469900104 · Cited by 42
Atrioventricular Nodal Reentrant Tachycardia in Patients With Congenital Heart Disease
Papagiannis, J. K., Beissel, D. J., Krause, U., Cabrera, M., Telishevska, M., Seslar, S. P., Johnsrude, C. L., Anderson, C. C., Tisma‐Dupanovic, S., Connelly, D., et al. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.004869 · Cited by 39
Fetal dysrhythmias
Api, O., & Carvalho, J. S. (2008) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2008.01.001 · Cited by 39
Usefulness of propafenone for supraventricular arrhythmias in infants and children
Janoušek, J., Paul, T., Reimer, A., & Kallfelz, H.-C. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90675-3 · Cited by 38
Intravenous flecainide for the treatment of junctional ectopic tachycardia after surgery for congenital heart disease
Bronzetti, G., Formigari, R., Giardini, A., Frascaroli, G., Gargiulo, G., & Picchio, F. M. (2003) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(03)00192-9 · Cited by 35
Programmed atrial stimulation via the esophagus for management of supraventricular arrhythmias in infants and children
Rhodes, L. A., Walsh, E. P., & Saul, J. P. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90402-2 · Cited by 34
2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: Executive summary
Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H. G., CONTI, J. B., Deal, B. J., Estes, N. A. M., Field, M. E., Goldberger, Z. D., Hammill, S. C., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.09.018 · Cited by 32
Cardiovascular Medication Errors in Children
Alexander, D. C., Bundy, D. G., Shore, A. D., Morlock, L., Hicks, R. W., & Miller, M. R. (2009) · PEDIATRICS · doi:10.1542/peds.2008-2073 · Cited by 31
Safety Issues in the Treatment of Paediatric Supraventricular Tachycardias
Pfammatter, P., & Bauersfeld, U. (1998) · Drug Safety · doi:10.2165/00002018-199818050-00004 · Cited by 30
Guías de Práctica Clínica del ACC/AHA/ESC 2006 sobre el manejo de pacientes con arritmias ventriculares y la prevención de la muerte cardiaca súbita.Versión resumida
Informe del Grupo de Trabajo del American College of Cardiology/American Heart Association, Súbita), D. C. D. G. D. P. C. D. L. S. E. D. C. (. P. E. D. D. G. D. P. C. P. E. M. D. P. C. A. V. Y. L. P. D. L. M. C., & desarrollado en colaboración con la European Heart Rhythm Association y la Heart Rhythm Society (2006) · Revista Española de Cardiología · doi:10.1157/13096582 · Cited by 30
Fetal arrhythmias: Diagnosis and management
Batra, A. S., & Balaji, S. (2019) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2019.02.007 · Cited by 26
Life-Threatening Flecainide Intoxication in a Young Child Secondary to Medication Error
D’Alessandro, L. C. A., Rieder, M. J., Gloor, J., Freeman, D., & Buffo-Sequiera, I. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l549 · Cited by 26
Sinus Node Dysfunction and Atrial Tachycardia After the Fontan Procedure: The Scope of the Problem
Cohen, M. I., & Rhodes, L. A. (1998) · Seminars in Thoracic and Cardiovascular Surgery Pediatric Cardiac Surgery Annual · doi:10.1016/s1092-9126(98)70008-0 · Cited by 26
Diretriz Brasileira de Dispositivos Cardíacos Eletrônicos Implantáveis – 2023
Teixeira, R. A., Fagundes, A. A., Baggio, J. M., de Oliveira, J. C., Medeiros, P. D. T. J., Valdigem, B. P., Teno, L. A. C., Silva, R. T., de Melo, C. S., Elías, J., et al. (2023) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20220892 · Cited by 53
Management of Infants with Idiopathic Dilatation of the Right Atrium and Atrial Tachycardia
Forbes, K., Kantoch, M. J., Divekar, A. A., Ross, D. B., & Rebeyka, I. M. (2007) · Pediatric Cardiology · doi:10.1007/s00246-006-0012-5 · Cited by 25
Atrial tachyarrhythmia in adult congenital heart disease
Karbassi, A., Nair, K., Harris, L., Wald, R. M., & Roche, S. L. (2017) · World Journal of Cardiology · doi:10.4330/wjc.v9.i6.496 · Cited by 27
Results of a restrictive use of antiarrhythmic drugs in the chronic treatment of atrioventricular reentrant tachycardias in infancy and childhood
Pfammatter, J., & Stocker, F. P. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00232-x · Cited by 25
Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults
Musto, B., Cavallaro, C., Musto, A., D’Onofrio, A., Belli, A., & Vincentis, L. D. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90927-n · Cited by 24
The Safety and Effectiveness of Flecainide in Children in the Current Era
Cunningham, T. C., Uzun, O., Morris, R., Franciosi, S., Wong, A., Jeremiasen, I., Sherwin, E. D., & Sanatani, S. (2017) · Pediatric Cardiology · doi:10.1007/s00246-017-1707-5 · Cited by 24
Recurrent ventricular tachycardia in asymptomatic young children with an apparently normal heart
Pfammatter, J., Paul, T., & Kallfelz, H. C. (1995) · European Journal of Pediatrics · doi:10.1007/bf02074824 · Cited by 24
Supraventricular tachycardia in neonates: antiarrhythmic drug choice dilemma
Tavera, M. C., Bassareo, P. P., Neroni, P., Follese, C., Manca, D., Montis, S., & Tumbarello, R. (2010) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2010.517937 · Cited by 23
Ablation of supraventricular arrhythmias in adult congenital heart disease: A contemporary review
Combes, N., Derval, N., Hascoët, S., Zhao, A., Amet, D., Bloa, M. L., Maltret, A., Heitz, F., Thambo, J., & Marijon, É. (2017) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2017.01.007 · Cited by 23
Re-entrant supraventricular tachycardia in infancy: current role of prophylactic digoxin treatment
Pfammatter, J., & Stocker, F. P. (1998) · European Journal of Pediatrics · doi:10.1007/s004310050778 · Cited by 23
Drug Therapy for Fetal Arrhythmias
Ito, S., Magee, L. A., & Smallhorn, J. F. (1994) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30331-2 · Cited by 23
Flecainide Use in Children with Cardiomyopathy or Structural Heart Disease
Moffett, B. S., Valdés, S. O., Lupo, P. J., delaUz, C. M., Miyake, C. Y., Krenek, M., & Kim, J. J. (2014) · Pediatric Cardiology · doi:10.1007/s00246-014-0978-3 · Cited by 22
Compared effects of sotalol, flecainide and propafenone on ventricular repolarization in patients free of underlying structural heart disease
Sarubbi, B., Ducceschi, V., Briglia, N., Mayer, M. S., Santangelo, L., & Iacono, A. (1998) · International Journal of Cardiology · doi:10.1016/s0167-5273(98)00201-0 · Cited by 22
A comparison of oral flecainide and amiodarone for the treatment of recurrent supraventricular tachycardia in children
Hill, A. C., Silka, M. J., & Bar‐Cohen, Y. (2019) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13662 · Cited by 21
Advanced mapping strategies for ablation therapy in adults with congenital heart disease
Alken, F., Klatt, N., Münkler, P., Scherschel, K., Jungen, C., Akbulak, R. Ö., Kahle, A., Gunawardene, M., Jularic, M., Dinshaw, L., et al. (2019) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2019.10.02 · Cited by 21
Differences in amiodarone, digoxin, flecainide and sotalol concentrations between antemortem serum and femoral postmortem blood
O'Sullivan, J., McCarthy, P., & Wren, C. (1995) · Human & Experimental Toxicology · doi:10.1177/096032719501400709 · Cited by 21
Atrial Fibrillation in Congenital Heart Disease
de Miguel, I. M., & Ávila, P. (2021) · European Cardiology · doi:10.15420/ecr.2020.41 · Cited by 20
Supraventricular Arrhythmias in Patients with Adult Congenital Heart Disease
Lundqvist, C. B., Potpara, T., & Malmborg, H. (2017) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2016:29:3 · Cited by 20
Arrhythmias in Structural Heart Disease
Gillespie, H. S., Lin, C. C. H., & Prutkin, J. M. (2014) · Current Cardiology Reports · doi:10.1007/s11886-014-0510-7 · Cited by 18
Flecainide-Induced Proarrhythmia Is Attributed to Abnormal Changes in Repolarization and Refractoriness in Perfused Guinea-Pig Heart
Osadchii, O. E. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31826b86cf · Cited by 19
Role of amiodarone in the management of atrial arrhythmias in adult Fontan patients
Kawada, S., Chakraborty, P., Roche, S. L., Oechslin, E. N., Silversides, C. K., Wald, R. M., Downar, E., Harris, L., Swan, L., Alonso-González, R., et al. (2020) · Heart · doi:10.1136/heartjnl-2020-317378 · Cited by 19
Electrophysiologic Therapeutics in Heart Failure in Adult Congenital Heart Disease
Motonaga, K. S., Khairy, P., & Dubin, A. M. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.09.011 · Cited by 19
Catheter Based Atrial Defibrillation
Wharton, J. M., & JOHNSON, E. E. (1994) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1994.tb01461.x · Cited by 18
DIAGNOSIS AND TREATMENT OF PEDIATRIC ARRHYTHMIAS
Case, C. L. (1999) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(05)70122-x · Cited by 15
Effects of Na+ Channel Blockers on Extrasystolic Stimulation-evoked Changes in Ventricular Conduction and Repolarization
Osadchii, O. E. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000041 · Cited by 14
Flecainide-Induced Increase in QRS Duration and Proarrhythmia during Exercise
Bordier, P., Garrigue, S., Bernard, V., Haı̈ssaguerre, M., Douard, H., Broustet, J. P., & Clémenty, J. (1997) · Clinical Drug Investigation · doi:10.2165/00044011-199713060-00005 · Cited by 13
Pediatric Cardiac Intensive Care Society 2014 Consensus Statement
Moffett, B. S., Salvin, J. W., & Kim, J. J. (2016) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000000620 · Cited by 13
Electrophysiological interventions for treatment of congestive heart failure in pediatrics and congenital heart disease
Dubin, A. M., & Berul, C. I. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.1.111 · Cited by 12
Overview of antiarrhythmic drug therapy for supraventricular tachycardia in children
Escudero, C. A., Carr, R. R., & Sanatani, S. (2013) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2012.11.008 · Cited by 12

Authors: Fish, F. A., Gillette, P. C., & Benson, D. W.
Affiliations: Northwestern University (US)
Medical University of South Carolina (US)
Corresponding author: Fish, Frank A
ORCID: Fish, Frank A
Benson, D.Woodrow
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 1991-08
Volume: 18
Issue: 2
Pages: 356-365
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/0735-1097(91)90586-x
OpenAlex: W2084942160
Cited by: 193
References: 37
Citations by year: 2026: 3 · 2025: 2 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 9 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 14 · 2016: 3 · 2015: 8 · 2014: 13 · 2013: 8 · 2012: 7
FWCI: 6.21
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 8020 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords: encainide, flecainide, class Ic antiarrhythmic drugs, drug-induced arrhythmia, cardiac arrest, drug-induced death, young patients, supraventricular tachycardia, ventricular arrhythmias, underlying heart disease, left ventricular shortening, adverse drug reactions, sodium channel blockers, plasma drug concentration, inpatient monitoring, drug safety and efficacy
MeSH terms: Anilides, Anti-Arrhythmia Agents, Arrhythmias, Cardiac, Child, Death, Sudden, Flecainide, Heart Arrest, Humans, Retrospective Studies, Risk Factors, Tachycardia, Tachycardia, Supraventricular, Incidence, Encainide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks